• 1
    Kempson GEH, Muir C, Pollard MT. The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans. Biochim Biophys Acta 1973; 297: 46772.
  • 2
    Mayne R. Cartilage collagens: what is their function, and are they involved in articular disease? Arthritis Rheum 1989; 32: 2416.
  • 3
    Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000; 14: 212333.
  • 4
    Walter H, Kawashima A, Nebelung W, Neumann W, Roessner A. Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. Pathol Res Pract 1998; 194: 7381.
  • 5
    Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001; 44: 58594.
  • 6
    McDonnell S, Morgan M, Lynch C. Role of matrix metalloproteinases in normal and disease processes. Biochem Soc Trans 1999; 27: 73440.
  • 7
    Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197250.
  • 8
    Mohtai M, Smith RL, Schurman DJ, Tsuji Y, Torti FM, Hutchinson NI, et al. Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest 1993; 92: 17985.
  • 9
    Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997; 99: 153445.
  • 10
    Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997; 378: 15160.
  • 11
    Vincenti MP, Coon CI, Mengshol JA, Yocum S, Mitchell P, Brinckerhoff CE. Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1). Biochem J 1998; 331: 3416.
  • 12
    Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo Y, Hoyland JA. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 1997; 56: 5429.
  • 13
    Joronen K, Salminen H, Glumoff V, Savontaus M, Vuorio E. Temporospatial expression of tissue inhibitors of matrix metalloproteinases-1, -2 and -3 during development, growth and aging of the mouse skeleton. Histochem Cell Biol 2000; 114: 15765.
  • 14
    Hayami T, Endo N, Tokunaga K, Yamagiwa H, Hatano H, Uchida M, et al. Spatiotemporal change of rat collagenase (MMP-13) mRNA expression in the development of the rat femoral neck. J Bone Miner Metab 2000; 18: 18593.
  • 15
    Chin JR, Werb Z. Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development 1997; 124: 151930.
  • 16
    Breckon JJ, Hembry RM, Reynolds JJ, Meikle MC. Regional and temporal changes in the synthesis of matrix metalloproteinases and TIMP-1 during development of the rabbit mandibular condyle. J Anat 1994; 184(Pt 1): 99110.
  • 17
    Bluteau G, Conrozier T, Mathieu P, Vignon E, Herbage D, Mallein-Gerin F. Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 2001; 1526: 14758.
  • 18
    Brama PA, TeKoppele JM, Beekman B, van Weeren PR, Barneveld A. Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis. Ann Rheum Dis 1998; 57: 6979.
  • 19
    Cimpean A, Caloianu M, Alexandru D, Efimov N, Buzgariu W. Effect of interleukin-1β on gelatinolytic activity and cell morphology of human osteoarthritic chondrocytes in culture. J Med Biochem 2000; 4: 11329.
  • 20
    Galboiz Y, Shapiro S, Lahat N, Rawashdeh H, Miller A. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) as markers of disease subtype and response to interferon-β therapy in relapsing and progressive multiple sclerosis patients. Annals Neurol 2001; 50: 4739.
  • 21
    Maiotti M, Monteleone G, Tarantino U, Fasciglione GF, Marini S, Coletta M. Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint. Arthroscopy 2000; 16: 5226.
  • 22
    Huhtala P, Tuuttila A, Chow LT, Lohi J, Keski-Oja J, Tryggvason K. Complete structure of the human gene for 92-kDa type IV collagenase: divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem 1991; 266: 1648590.
  • 23
    Thompson CC, Clegg PD, Carter SD. Differential regulation of gelatinases by transforming growth factor beta-1 in normal equine chondrocytes. Osteoarthritis Cartilage 2001; 9: 32531.
  • 24
    Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: purification and activation of the precursor and enzymic properties. J Biol Chem 1992; 267: 217129.
  • 25
    Matrisian LM. Matrix metalloproteinases gene expression. Ann N Y Acad Sci 2001; 732: 4250.
  • 26
    Livne E, Laufer D, Blumenfeld I. Differential response of articular cartilage from young, growing and mature old mice to interleukin-1 and TGF-β. Arch Gerontol G 1996; 24: 21121.
  • 27
    Stahle-Backdahl M, Sandstedt B, Bruce K, Lindahl A, Jimenez MG, Vega JA, et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 1997; 76: 71728.
  • 28
    Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, et al. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 1997; 208: 38797.
  • 29
    Gack S, Vallon R, Schmidt J, Grigoriadis A, Tuckermann J, Schenkel J, et al. Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Differ 1995; 6: 75967.
  • 30
    Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis. J Clin Invest 1996; 97: 20119.
  • 31
    Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996; 97: 7618.
  • 32
    Henriet P, Rousseau GG, Eeckhout Y. Cloning and sequencing of mouse collagenase cDNA: divergence of mouse and rat collagenases from the other mammalian collagenases. FEBS Lett 1992; 310: 1758.
  • 33
    Shlopov BV, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997; 40: 206574.
  • 34
    Wolfe GC, MacNaul KL, Buechel FF, McDonnell J, Hoerrner LA, Lark MW, et al. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage: quantitative comparison with stromelysin messenger RNA levels in human rheumatoid arthritis and osteoarthritis patients and in two animal models of acute inflammatory arthritis. Arthritis Rheum 1993; 36: 15407.
  • 35
    Murphy G, Hembry RM, Hughes CE, Fosang AJ, Hardingham TE. Role and regulation of metalloproteinases in connective tissue turnover. Biochem Soc Trans 1990; 18: 8125.
  • 36
    Huebner JL, Otterness IG, Freund EM, Caterson B, Krauss V. Collagenase 1 and collagenase 3 expression in a guinea pig model of osteoarthritis. Arthritis Rheum 1998; 41: 87790.
  • 37
    Balbin M, Fueyo A, Knauper V, Lopez JM, Alvarez J, Sanchez LM, et al. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem 2001; 276: 1025362.
  • 38
    Chubinskaya S, Kueter KE, Cole AA. Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints. Lab Invest 1999; 79: 166977.
  • 39
    D'Angelo M, Yan Z, Nooreyazdan M, Pacifici M, Sarment DS, Billings PC, et al. MMP-13 is induced during chondrocyte hypertrophy. J Cell Biochem 2000; 77: 67893.
  • 40
    Livne E. Matrix synthesis in mandibular condylar cartilage of aging mice. Osteoarthritis Cartilage 1994; 2: 18797.
  • 41
    Jeffrey JE, Thomson LA, Aspden RM. Matrix loss and synthesis following a single impact load on articular cartilage in vitro. Biochim Biophys Acta 1997; 1334: 22332.
  • 42
    Steinmeyer J, Knue S. The proteoglycan metabolism of mature bovine articular cartilage explants superimposed to continuously applied cyclic mechanical loading. Biochem Biophys Res Commun 1997; 240: 21621.
  • 43
    Jin G, Sah RL, Li YS, Lotz M, Shyy JY, Chien S. Biomechanical regulation of matrix metalloproteinase-9 in cultured chondrocytes. J Orthop Res 2000; 18: 899908.
  • 44
    Smith RL, Donlon BS, Gupta MK, Mohtai M, Das P, Carter DR, et al. Effects of fluid-induced shear on articular chondrocyte morphology and metabolism in vitro. J Orthop Res 1995; 13: 82431.
  • 45
    Blain EJ, Gilbert SJ, Wardale RJ, Capper SJ, Mason DJ, Duance VC. Up-regulation of matrix metalloproteinase expression and activation following cyclical compressive loading of articular cartilage in vitro. Arch Biochem Biophys 2001; 396: 4955.